Life Sciences

Life Sciences Articles by Topic: Drug Safety

Genentech withdraws Raptiva

  • Pharma Compliance Alert, Issue 16, April 22, 2009

    Genentech is voluntarily withdrawing its psoriasis drug Raptiva from the U.S. market because of the...

Caraco recalls Digoxin tablets

  • Pharma Compliance Alert, Issue 14, April 8, 2009

    Caraco Laboratories issued a recall for its Digoxin tablets because they may differ in size and...

Court documents: AstraZeneca knew about Seroquel diabetes risks in 2000

  • Pharma Compliance Alert, Issue 49, December 10, 2008

    It just got tougher for AstraZeneca to defend itself in lawsuits centering on its antipsychotic...

Nevada AG claims pharma companies marketed products deceptively

  • Pharma Compliance Alert, Issue 47, November 26, 2008

    Nevada Attorney General Catherine Cortez Masto filed suit against Wyeth and Pfizer, claiming...

Supreme Court hears arguments in preemption case

  • Pharma Compliance Alert, Issue 44, November 5, 2008

    The Supreme Court will determine whether consumers can sue pharmaceutical companies for injuries...

Lilly nears federal Zyprexa settlement

  • Pharma Compliance Alert, Issue 43, October 29, 2008

    Eli Lilly’s total legal expenses for suits relating to its antipsychotic medication Zyprexa...

Pfizer to settle Bextra, Celebrex claims for $894M

  • Pharma Compliance Alert, Issue 42, October 22, 2008

    Pfizer has agreed in principle to pay $894 million to settle all lawsuits related to its...

Wyeth releases its side of story for upcoming preemption case

  • Pharma Compliance Alert, Issue 42, October 22, 2008

    The Supreme Court is set to begin hearing arguments in Wyeth v. Levine November 3, and Wyeth issued...

Pfizer accused of suppressing Neurontin study

  • Pharma Compliance Alert, Issue 41, October 15, 2008

    Pfizer marketing executives allegedly knew Neurontin, an epilepsy drug, did not effectively treat...

DOJ withdraws motion against Ranbaxy

  • Pharma Compliance Alert, Issue 41, October 15, 2008

    Generic drug maker Ranbaxy agreed to turn over audits to the Department of Justice (DOJ), and in...

California appeals court rules FDA label doesn't protect manufacturer

  • Pharma Compliance Alert, Issue 40, October 8, 2008

    The California Fifth District Court of Appeal in Fresno reinstated a Modesto woman’s suit...

GSK settles Paxil suit

  • Pharma Compliance Alert, Issue 40, October 8, 2008

    GlaxoSmithKline (GSK) will pay $40 million to settle a class action lawsuit with 42,000 health...

FDA issues warning letters to Ranbanxy

  • Pharma Compliance Alert, Issue 38, September 24, 2008

    Two of generic drug manufacturer Ranbaxy’s plants allegedly violated U.S. current Good...

Pfizer creates Web site on medication safety

  • Pharma Compliance Alert, Issue 37, September 17, 2008

    Pfizer launched a new Web site Monday to provide patients and healthcare professionals with...